Literature DB >> 3714622

The use of lumbar puncture in a district general hospital.

D B Oliveira.   

Abstract

A survey of lumbar punctures performed in adults in a district general hospital over a two year period was carried out. As well as being used for conventional, specific indications, lumbar puncture was often employed as a screening investigation in undiagnosed neurological illness. Although this was not inappropriate in patients with meningeal symptoms and signs, or patients with disordered consciousness, lumbar puncture was also used in patients with focal neurological signs. Although the dangers of lumbar puncture in these latter patients, and the fact that it is unlikely to yield information unobtainable by other investigations have been stated by many authorities, almost 20% of patients fell into this group. This suggests that these points require further emphasis.

Entities:  

Mesh:

Year:  1986        PMID: 3714622      PMCID: PMC2418677          DOI: 10.1136/pgmj.62.726.277

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Lumbar puncture in the presence of raised intracranial pressure.

Authors:  G P Duffy
Journal:  Br Med J       Date:  1969-02-15

2.  Lumbar puncture in spontaneous subarachnoid hemorrhage.

Authors:  P J Teddy; M Briggs; C B Adams
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

3.  Lumbar puncture in spontaneous subarachnoid haemorrhage.

Authors:  G P Duffy
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

4.  Computer-assisted (axial) tomography in the management of subarachnoid haemorrhage.

Authors:  G F Findlay
Journal:  Surg Neurol       Date:  1980-02

5.  The lumbar puncture. Patterns of use in clinical practice.

Authors:  K I Marton; M I Vender
Journal:  Med Decis Making       Date:  1981       Impact factor: 2.583

  5 in total
  1 in total

1.  Emergency lumbar puncture in adults.

Authors:  R L Macdonald; M Bernstein
Journal:  Can Fam Physician       Date:  1989-05       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.